Using machine learning to characterize heart failure across the scales by Peirlinck, Mathias et al.
Biomechanics and Modeling in Mechanobiology
doi: 10.1007/s10237-019-01190-w
(final version before typesetting)
Using machine learning
to characterize heart failure across the scales
M. Peirlinck · F. Sahli Costabal · K.L. Sack · J.S. Choy · G.S. Kassab ·
J.M. Guccione · M. De Beule · P. Segers · E. Kuhl
Received: 6 March 2019 / Accepted: 16 June 2019
Abstract Heart failure is a progressive chronic condi-
tion in which the heart undergoes detrimental changes
in structure and function across multiple scales in time
and space. Multiscale models of cardiac growth can pro-
vide a patient-specific window into the progression of
heart failure and guide personalized treatment plan-
ning. Yet, the predictive potential of cardiac growth
models remains poorly understood. Here we quantify
predictive power of a stretch-driven growth model using
a chronic porcine heart failure model, subject-specific
multiscale simulation, and machine learning techniques.
We combine hierarchical modeling, Bayesian inference,
and Gaussian process regression to quantify the un-
certainty of our experimental measurements during an
eight-week long study of volume-overload in six pigs.
We then propagate the experimental uncertainties from
the organ scale through our computational growth
model and quantify the agreement between experimen-
tally measured and computationally predicted alter-
ations on the cellular scale. Our study suggests that
stretch is the major stimulus for myocyte lengthening
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and demonstrates that a stretch-driven growth model
alone can explain 52.7% of the observed changes in my-
ocyte morphology. We anticipate that our approach will
allow us to design, calibrate, and validate a new genera-
tion of multiscale cardiac growth models to explore the
interplay of various subcellular, cellular, and organ level
contributors to heart failure. Using machine learning in
heart failure research has the potential to combine in-
formation from different sources, subjects, and scales to
provide a more holistic picture of the failing heart and
point towards new treatment strategies.
Keywords Machine learning · Gaussian process
regression · Bayesian inference · uncertainty quan-
tification · heart failure · growth and remodeling ·
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1 Motivation
Cardiovascular disease is the single leading cause of
death worldwide with an estimated 17.3 million deaths
in 2016, representing 31.5% of all global deaths [61].
With a 5-year mortality rate of 50%, heart failure
remains–and will remain in the foreseeable future–one
of the most common, costly, disabling, and deadly med-
ical conditions. In a traditional biomechanics sense,
cardiac growth and remodeling, can be considered a
protective and reparative homeostatic mechanism [20].
However, when combined with chronic alterations in the
heart’s loading conditions, these mechanisms lead to
pathoanatomical changes that compromise the heart’s
electrical and mechanical function [52]. The underly-
ing structural alternations can be categorized in two
major patterns: eccentric hypertrophy associated with
myocyte lengthening caused by a chronic overload in
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Fig. 1 Using machine learning and multiscale modeling to characterize heart failure across the scales. We
characterize end diastolic and systolic volumes, myocyte widths and lengths, and sarcomere numbers and length in a longi-
tudinal study of volume overload using cardiac echocardiography, tissue histology, and multiscale modeling. We quantify the
agreement between simulation and experiment in terms of the myocyte lengths recorded in six animals throughout a period
of eight weeks.
volume and concentric hypertrophy associated with my-
ocyte thickening caused by a chronic overload in pres-
sure [17]. Eccentric hypertrophy results in enlarged,
dilated ventricles at a relatively constant wall thick-
ness while concentric hypertrophy results in thickened
ventricular walls at a relatively constant cardiac size
[16]. In addition to a compromised mechanical func-
tion, these pathoanatomical changes distort the heart’s
electrical activation and conductivity resulting in an
increasingly higher risk for ischemia, arrhythmia, and
sudden death [25].
One of the most pertinent clinical questions in treat-
ment planning is to anticipate and predict the rate of
disease progression [65]. Consequently, the mechanobi-
ological factors that regulate cardiac hypertrophy have
been the subject of extensive research throughout the
past decades [40]. Cardiac growth models have the po-
tential to provide mechanistic insight in disease on-
set and progression [46] and can aid clinical decision-
making or the design of emerging therapies [6]. Yet,
a considerable debate remains around the underlying
stimuli that trigger cardiac growth. Increasing evidence
points to mechanical factors as mediating stimuli, both
at the tissue and cellular levels. In eccentric hyper-
trophy, initial studies suggested that the end-diastolic
stress would trigger cardiac dilation [19], while later
studies opposed this hypothesis and suggested the end-
diastolic stretch as a stimulus for cardiac growth [39].
Here we explore this hypothesis and characterize to
which extent a mechanistic stretch-driven growth model
can explain cardiac dilation in a unique chronic animal
study where we induce and characterize eccentric hy-
pertrophy across multiple lengths scales.
2 Methods
Figure 1 outlines the design of our study. To corre-
late whole organ, tissue, cellular, and subcellular lev-
els, we use a multiscale continuum growth model. We
characterize end diastolic volumes and myocyte dimen-
sions in a longitudinal study of volume overload using
echocardiography and tissue histology. To account for
uncertainties in both sets of measurements, we com-
bine Bayesian inference, uncertainty quantification, and
Gaussian process regression. To quantify the predictive
potential of our multiscale growth model, we character-
ize the agreement between the computationally simu-
lated and experimentally measured myocyte lengths for
six animals throughout a period of eight weeks.
2.1 Animal model
All animal experiments were performed at the Cali-
fornia Medical Innovations Institute animal care facil-
ities following an approved IACUC protocol according
to national and local ethical guidelines, including the
Guide for the Care and Use of Laboratory Animals,
the Public Health Service Policy on Humane Care and
Use of Laboratory Animals, and the Animal Welfare
Act. As previously described [7,53], our study included
six Yorkshire domestic pigs of either sex with a body
weight of 46.3± 8.0 kg. At the day of surgery, the an-
imals were sedated with telazol-ketamine-xylazine and
anesthesia was maintained with isoflurane. To moni-
tor the pressure and provide access to the left ven-
tricle for mitral valve chordae disruption, we percuta-
neously inserted sheaths into the jugular vein to admin-
ister fluids and drugs into the right femoral artery. Us-
ing transesophageal echocardiography guidance, mod-
erate to severe mitral regurgitation was created by dis-
rupting one or more chordae. The degree of regurgi-
tation was confirmed using echocardiography. At the
day of surgery and then bi-weekly for a period of eight
weeks, transthoracic and transesophageal echocardio-
grams were recorded and endomyocardial biopsy sam-
ples were collected. For the organ level characterization,
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we recorded echocardiographic images, two- and three-
dimensional in short and long axis views, with the an-
imal in the supine and left lateral decubitus positions.
From these images, we automatically constructed dy-
namic surface models of the left ventricle to extract
end-diastolic volumes, end-systolic volumes, stroke vol-
umes, ejection fractions, and wall thicknesses. For the
cell level characterization, four to six endomyocardial
biopsy samples were collected from the apex and the left
ventricular free wall. We incubated the samples in car-
dioplegic solution at 37oC, prepared 7-µm-thick slices,
mounted them on glass slides, and incubated them
with Wheat Germ Agglutinin to characterize myocyte
widths and lengths and with Anti-Sarcomeric Alpha
Actinin to characterize sarcomere numbers and lengths.
Under fluorescence microscopy, the images were merged
using ImageJ to identify the sarcomere numbers within
each myocyte. At eight-weeks post surgery, the mea-
surement protocol was terminated. At that time we
deeply anesthetized the animal, arrested the heart in
diastole with potassium chloride, and excised the heart.
Finally, transmural punch biopsies were collected from
the apex and free wall.
2.2 Multiscale model of cardiac growth
To correlate the changes in end diastolic volume to
changes in myocyte length and width, we adopt the
theory of finite growth [48]. This theory postulates a
multiplicative decomposition of the deformation gradi-
ent F = ∇ϕ, the gradient of the nonlinear deformation
map ϕ, into an elastic tensor F e and a growth tensor
F g [1,30],
F = ∇ϕ = F e · F g . (1)
We assume that growth is transversely isotropic with
respect to the myocyte direction n [37,66],
F g = ϑ‖n⊗ n+ ϑ⊥[ I − n⊗ n ] , (2)
and interpret the scalar longitudinal and transverse
growth ϑ‖ and ϑ⊥ as the relative changes in myocyte
length and myocyte width [38,64]. Values of ϑ = 1 rep-
resent no change in myocyte dimensions, values of ϑ > 1
represent myocyte lengthening and thickening. Figure 2
illustrates the kinematics of our growth model, with the
deformation ϕ, the deformation gradient F , the elastic
tensor F e, and the growth tensor F g as a direct re-
sult of the changes in myocyte length ϑ‖ and width ϑ⊥.
For the baseline elastic material response, we adopt the
ϕ(X ,t)
Fg Fe
F =∇ϕ  
Fig. 2 Multiscale model of cardiac growth. Multiplica-
tive decomposition of the deformation gradient F = ∇ϕ =
F e · F g into an elastic tensor F e and a growth tensor F g;
the growth tensor F g = ϑ‖n⊗n+ϑ⊥[ I−n⊗n ] introduces
the longitudinal and transverse growth ϑ‖ and ϑ⊥, which are
directly correlated to changes in myocyte length and width.
classical Holzapfel-Ogden model [22],
ψ =
a
2b
exp(b[Ie1− 3]) +
af
2bf
[exp(bf [I
e
4f− 1]2)− 1]
+
as
2bs
[exp(bs[I
e
4s− 1]2)− 1] +
afs
2bfs
[exp(bfs(I
e
8fs)
2)− 1],
(3)
where Ie1 , I
e
4f , I
e
4s, and I
e
8fs are the invariants that char-
acterize the trace of the right elastic Cauchy Green de-
formation tensor, the elastic fiber stretch, sheet stretch,
and coupled fiber-sheet stretch in terms of the elastic
tensor F e [18] and a, b, af , bf , as, bs, afs, and bfs are
the eight Holzapfel-Ogden material parameters. For the
volume overload growth response, we adopt an estab-
lished stretch-driven growth model in the longitudinal
direction and assume that there is no growth in the
thickness direction [16,45,65],
ϑ˙‖ =
1
τ
〈λe − λcrit〉 and ϑ˙⊥ = 0 . (4)
The Macauley brackets 〈 〉 activate longitudinal growth
only if the elastic fiber stretch, λe = [n ·F e t ·F e ·n ]1/2,
exceeds the homeostatic baseline stretch, λcrit. Impor-
tantly, λcrit is not a free parameter; it is the regionally
varying homeostatic baseline stretch at end diastole,
that we determine from a baseline simulation prior to
inducing volume overload [51]. For λe ≤ λcrit, there is
no growth; for λe > λcrit, the growth parameter τ con-
trols the speed of growth.
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2.3 Computational model
We simulate volume-overload induced growth using the
finite element software package Abaqus [3]. For each an-
imal, we create a finite element model of the left ventri-
cle using the subject-specific echocardiography images
at the minimum cavity volume of the cardiac cycle and
assume that this is the stress free state. Figure 2 shows
a typical left ventricular model discretized with 3,456
linear hexahedral elements, 4,152 nodes, and 12,456 de-
grees of freedom. We assign each element a discrete fiber
orientation n using a rule-based approach [34] in which
the fiber angles vary from +60o in the endocardium to
−60o in epicardium [62]. We load the heart in two steps,
homeostatic loading and pathologic overloading. For
homeostatic loading, we load the ventricle to the experi-
mentally recorded end diastolic volume and record and
store the maximum stretch at each integration point
as the critical stretch λcrit beyond which we activate
growth. For pathologic overloading, we gradually in-
crease the end diastolic volume. This results in an in-
crease in the elastic fiber stretch λe, which activates
growth and triggers an increase in myocyte length ϑ‖.
2.4 Parameter identification of elastic parameters
To calibrate the eight Holzapfel-Ogden material pa-
rameters for each animal, we adopt a new two-stage
approach [50]. First, we characterize an initial set of
Holzapfel-Ogden parameters a¯, b¯, a¯f , b¯f , a¯s, b¯s, a¯fs, b¯fs
that reproduces ex vivo triaxial shear tests of human
myocardial tissue [59]. Then, we map this set of ex vivo
parameters onto our in vivo stiffness parameters a, af ,
as, and afs and our in vivo exponential parameters b,
bf , bs, and bfs via two scaling coefficients α and β as
ai = α a¯i and bi = β b¯i [50]. To calibrate the scaling
coefficients α and β, we minimize the error between the
analytical Klotz curve of the experimentally recorded
end-diastolic pressure-volume relation at baseline [28]
and the computationally simulated diastolic pressure-
volume relation using Abaqus [8] and a sequential least
squares programming optimization algorithm [24]. For
the resulting set of in vivo Holzapfel-Ogden material
parameters, the recorded end diastolic pressure inflates
the ventricle from the recorded minimal volume to the
recorded end diastolic volume, at which we record and
store the homeostatic baseline stretch λcrit at each in-
tegration point.
2.5 Sensitivity analysis of growth speed
To explore the effects of the kinetics of growth, we
systematically vary the only free parameter in the
growth equation (4), the growth parameter τ . We
explore a wide range of growth parameters, τ =
[ 0.03, 0.10, 0.33, 1.00, 3.33, 10.00 ] week, and highlight
their effect on the longitudinal growth ϑ‖, the longi-
tudinal growth rate ϑ˙‖, and the elastic stretch in the
fiber direction λe. From this sensitivity analysis, we ra-
tionalize a growth parameter of τ = 0.1 week, which
we use for all further studies. This value ensures a suffi-
ciently rapid linear growth response to hemodynamic
alterations which matches the quasi-constant growth
rates observed in other experimental studies [63]. Im-
portantly, throughout the entire process, we do not in-
troduce any cellular information from tissue histology
to prescribe growth as we have done in a previous study
[53]. Rather, we use this cellular information to objec-
tively assess the predictive power of the growth law.
2.6 Uncertainty quantification using Bayesian inference
To characterize volume-overload-induced changes in
our organ and cell level variables, we employ Bayesian
inference [53]. For all recorded samples, we postulate
that our measurements are drawn from distributions
that evolve in time. To ensure that the end diastolic
volumes, myocyte lengths, and myocyte widths take
positive values at all times, we assume that they are
log-normally distributed at any point in time [36]. We
further postulate that the myocyte length and width are
correlated through a bivariate log-normal likelihood,[
log(yi,jml)
log(yi,jmw)
]
∼ N
([
µiml(tj)
µimw(tj)
]
,Σ
)
, (5)
where yi,jml and y
i,j
mw are the myocyte length and width
measurements j of subject i, µiml(tj) and µ
i
mw(tj) are
the means of their distributions at the time of measure-
ment j, and Σ is the covariance matrix between these
quantities. For the end diastolic volume, we assume a
simple log-normal likelihood,
log(yi,jed ) ∼ N (µied(tj), σed), (6)
where yi,jed is the jth end diastolic volume measurement
for subject i, µied(tj) is the mean of its distribution at
the time of measurement j, and σed is the standard
deviation. We propose a linear relationship between the
mean and time,
µik(t) = a
i
k + b
i
kt with k = {ed,ml,mw} , (7)
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where aik and b
i
k represent the intercept and slope
of the line µk(t) for subject i and k represents the
end diastolic volume (ed), the myocyte length (ml)
and the myocyte width (mw) respectively. To take
into account the variability between subjects and, at
the same time, take advantage of the entire acquired
dataset, we postulate a hierarchical model [12]. Specifi-
cally, we assume that the different parameters of the
model in equation (7) for each subject i are drawn
from normal distributions, aik ∼ N (µak, σak) and bik ∼
N (µbk, σbk). Altogether, this approach introduces four
hyper-parameters, µak, µ
b
k, σ
a
k and σ
b
k, which control
the variability between the intercept aik and slope b
i
k
for each subject i. We can now estimate the individ-
ual response of each subject by considering the total-
ity of the cohort. To complete our statistical model
in a Bayesian setting, we select weakly informative
priors and select our hyper parameters as µak, µ
b
k ∼
N (0, 1002) and σak , σbk ∼ Half-Cauchy(γ = 10) [11], and
our remaining parameters as σk ∼ Half-Cauchy(γ =
100) and Σ ∼ LKJ(η = 2), where LKJ denotes the
Lewandowski-Kurowicka-Joe distribution [35]. This dis-
tribution is particularly suitable for multi-variate nor-
mal co-variance matrices [55]. Finally, we compute pos-
terior distributions for the parameters using Bayes’ the-
orem. We perform statistical inference using a Hamilto-
nian Monte Carlo method implemented in PyMC3 [55].
We then compute new samples of our quantities of in-
terest yk from a predictive posterior distribution at dif-
ferent time points and illustrate the discrete measure-
ment points, their medians, their 95% confidence in-
tervals, and their inferred probability density functions
throughout our entire study interval of eight weeks.
2.7 Uncertainty propagation using Gaussian process
regression
To correlate the organ and cellular levels, we prop-
agate the uncertainty of our experimental measure-
ments through our computational model [54]. To ac-
count for the uncertainty on the organ level, we propa-
gate the volume overload uncertainty to the predicted
longitudinal growth. For each subject, ex supra, we
characterize the uncertainty on the end diastolic vol-
ume, exp
(
aied
)
exp
(
biedt
)
, through hierarchical model-
ing and Bayesian modeling in terms of the parameters
aied and b
i
ed. Specifically, we normalize the volume over-
load by its value exp
(
aied
)
at time t = 0, such that
ed = exp
(
biedt
)
, and characterize it by the last 500
samples of bed from the Hamiltonian Monte Carlo chain.
However, instead of performing a single forward growth
simulation for each of these 500 samples, we train a
Gaussian process regression [43,44] to predict the me-
dian longitudinal growth ϑ˜‖ = f( t, ed ) as a function of
the time t and the normalized end diastolic volume ed.
For each subject, in the expected range of uncertainty,
we perform n = 20 simulations for training and an ad-
ditional n = 10 simulations for validation [42]. Since the
intermediate steps towards the final solution are also
valid data points, this represents a total of 621 points
for training and 311 points for validation for each sub-
ject. After training the Gaussian process regression on
the training set, the root mean squared error in me-
dian growth on the validation set was less than 0.27%
for all animals. Once validated, we use the Gaussian
process regression f to propagate the 500 samples of
bed that characterize the volume overload uncertainty
through the multiscale growth model. From these 500
samples, we determine the median longitudinal growth
at 31 time points between weeks 0 and 8. In total, this
approach systematically generates 15,500 values of ϑ˜‖
for each subject.
To account for the uncertainty in our cellular mea-
surements, we correlate the longitudinal growth, ϑ‖ =
exp(bml t), to the parameter bml from the experimen-
tally measured histology in equation (7). Similar to
the volume overload, we normalize the myocyte length,
exp(aml) exp(bmlt), from equation (5) by its initial value
exp(aml) at time t = 0 to obtain ml(t) = exp(bmlt) [53].
To quantify the agreement between the simulated and
experimental longitudinal growth ϑ‖, we compute the
probability density functions of both distributions at
week 8 and determine the overlap as the percentage
agreement between both probability density functions.
3 Results
3.1 End diastolic volumes increase with volume
overload
Table 1 summarizes our echocardiography measure-
ments at baseline and throughout a bi-weekly follow
up period of eight weeks of volume overload. Alto-
gether, we collected n = 28 measurements of end dias-
tolic and end systolic volumes. The mean end diastolic
and end systolic volumes increased from 67.9± 20.6ml
and 30.2± 9.5ml at baseline to 100.2± 17.9ml and
51.3± 9.0ml at week eight. This defines a decrease in
ejection fraction from 55.6± 4.9% to 47.7± 9.5%. Fig-
ure 3 shows the end diastolic volumes in all six an-
imals in response to eight weeks of ventricular vol-
ume overload. The gray cross markers represent the
n = 28 individual measurements, the solid black lines
represent their medians, and dashed black lines their
6 M. Peirlinck et al.
Table 1 Changes in end diastolic volume ed, end systolic
volume es, myocyte length ml, myocyte width mw, sar-
comere number sn, and sarcomere length sl in response to
left ventricular volume overload. Results are summarized as
mean ± standard deviation.
w0 w2 w4 w6 w8 ∆/week
ed 67.9 71.3 77.7 86.8 100.2 +5.95%
[ml] ±20.6 ±11.0 ±9.5 ±13.4 ±17.9
es 30.2 34.4 40.1 44.6 51.3 +8.73%
[ml] ±9.5 ±7.2 ±7.8 ±5.7 ±9.0
ml 85.45 84.77 86.85 84.38 107.75 +3.26%
[µm] ±22.30 ±17.17 ±18.45 ±18.93 ±26.57
mw 13.67 13.04 14.19 13.85 12.98 −0.63%
[µm] ±3.73 ±3.20 ±2.96 ±2.92 ±3.01
sn 47.50 49.91 50.36 49.97 62.07 +3.83%
[−] ±11.67 ±9.96 ±10.76 ±11.62 ±16.35
sl 1.75 1.78 1.75 1.76 1.77 +0.14%
[µm] ±0.15 ±0.13 ±0.10 ±0.10 ±0.11
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Fig. 3 Evolution of end diastolic volumes in response
to left ventricular volume overload. Gray cross markers
represent n = 28 individual measurements of end diastolic
volume, solid lines represent their medians, and dashed lines
their 95% confidence intervals. Color contours from dark to
light highlight the probability density from high to low.
95% confidence intervals. The mean end diastolic vol-
ume increased by +5.95%/week, with a rapid increase
between weeks 6 and 8. The direct comparison be-
tween the six animals illustrates the inter-animal vari-
ation: Pig #3 displayed the largest increase in end di-
astolic volume with +12.4%/week, pig #1 the small-
est with +2.5%/week. Since the end systolic volume
increased by +8.73%/week, more rapidly than the end
diastolic volume, the overall ejection fraction decreased,
by −1.78%/week. As the hearts dilated, the left ventric-
ular mass increased by 9.88%/week.
3.2 Myocyte lengths increase with volume overload
Next to the echocardiography measurements, Table
1 also summarizes the histological measurements at
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Fig. 4 Evolution of myocyte lengths in response to
left ventricular volume overload. Gray cross markers rep-
resent n = 460 individual measurements of myocyte lengths,
solid black lines represent their medians, and dashed black
lines their 95% confidence intervals. Color contours from dark
to light highlight the probability density from high to low.
baseline and throughout a bi-weekly follow up pe-
riod of eight weeks of volume overload. Altogether,
n = 460 measurements of myocyte length and width
were collected. The mean myocyte length increased,
from 85.45± 22.30µm to 107.75± 26.57µm, with a rel-
atively constant myocyte length throughout the first
six weeks and a steep increase between weeks 6 and 8.
At the same time, the mean myocyte width remained
virtually constant at 13.55µm, varying marginally be-
tween minimum values of 12.98± 3.01µm and maxi-
mum values of 14.19± 2.92µm. Figure 4 illustrates the
myocyte length in all six animals in response to eight
weeks of ventricular volume overload. The gray cross
markers represent the n = 460 individual measure-
ments, the solid black lines represent their medians, and
dashed black lines their 95% confidence intervals. The
mean myocyte length in Figure 4 increased markedly,
by +3.26%/week, with a rapid increase between weeks
6 and 8. The direct comparison between the six ani-
mals illustrates the inter-animal variation: Pig #2 dis-
played the largest increase in myocyte length with
+6.9%/week, pig #5 the smallest with +2.2%/week.
Figure 5 illustrates the myocyte widths in all six ani-
mals in response to eight weeks of ventricular volume
overload. The gray cross markers represent the n = 460
individual measurements, the solid black lines repre-
sent their medians, and dashed black lines their 95%
confidence intervals. The mean myocyte width in Fig-
ure 5 varied only marginally, by −0.63%/week. Pig #2
displayed the largest increase in myocyte width with
+0.7%/week, whereas pig #6 showed the largest de-
crease with −0.9%/week. This marginal change in my-
ocyte width justifies the assumption of a constant my-
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Fig. 5 Evolution of myocyte widths in response to left
ventricular volume overload. Gray cross markers repre-
sent n = 460 individual measurements of myocyte widths,
solid black lines represent their medians, and dashed black
lines their 95% confidence intervals. Color contours from dark
to light highlight the probability density from high to low.
ocyte width ϑ⊥ = 1 and ϑ˙⊥ = 0 in equation (4) of our
growth model.
3.3 Elastic behavior in vivo is softer than ex vivo
Figure 6 depicts the fitted diastolic filling response for
each pig following the subject-specific two-stage pas-
sive myocardial tissue reponse calibration. Table 2 sum-
marizes our in vivo Holzapfel-Ogden material parame-
ters for each animal in comparison to ex vivo human
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Fig. 6 Two-stage passive constitutive myocardial tis-
sue response calibration. Dashed lines represent the dias-
tolic filling pressure-volume relation based on ex vivo human
Holzapfel-Ogden material parameters from the literature [50,
59], cross markers depict the theoretical end diastolic pres-
sure volume relation (Klotz-curve) deduced from the experi-
mentally measured subject-specific end diastolic pressure vol-
ume data [28] and solid lines depict the passive material re-
sponse fitted to represent the subject-specific passive in vivo
response.
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Fig. 7 Sensitivity analysis of growth with respect to
the growth speed τ . Longitudinal growth ϑ‖, longitudi-
nal growth rate ϑ˙‖, and elastic stretch in the fiber direction
λe averaged over the ventricle for varying growth speeds τ ,
here illustrated for pig #4. Solid lines represent the medians
and shaded regions their 95% confidence intervals across the
ventricle.
Holzapfel-Ogden material parameters from the litera-
ture [50,59]. We consistently identified stiffness param-
eters of the same order of magnitude, with a mean
isotropic stiffness of a = 153.3 ± 41.5 Pa, and mean
fiber and sheet stiffnesses of af = 505.4 ± 136.9 Pa,
as = 70.2±19.0 Pa, and afs = 41.2±11.2 Pa. The expo-
nential parameters varied from b = 4.97 ± 0.71 for the
isotropic term to bf = 9.54± 1.36, bs = 8.27± 1.18, and
bfs = 2.04±0.29 for the fiber and sheet terms. Notably,
the stiffness parameters ai = α a¯i took values on the
order of α = 14.60±3.95% of their ex vivo human coun-
terparts a¯. The exponential parameters bi = β b¯i were
also smaller than their ex vivo human counterparts b¯,
but only by β = 65.93±9.40%. The standard deviations
in the two scaling parameters were small, 27.05% and
14.26 % of their means, suggesting that our inversely
identified in vivo stiffness parameters are consistently
smaller than their ex vivo counterparts recorded [59]
and identified [50] in the literature.
3.4 Growth displays temporal and regional variations
Figure 7 illustrates the results of our sensitivity anal-
ysis with respect to the growth speed τ . The three
graphs show the longitudinal growth ϑ‖, the longitu-
dinal growth rate ϑ˙‖, and elastic stretch in the fiber di-
rection λe for varying growth speeds τ evaluated for pig
#4. The solid lines represent the medians and shaded
regions their 95% confidence intervals. According to
equation (4), the parameter τ is inversely proportional
to the longitudinal growth rate, ϑ˙‖ ∼ 1/τ , as long as
the elastic stretch λe exceeds the homeostatic base-
line stretch λcrit. In the limit of τ → 0, growth would
take place instantaneously and the elastic stretch would
immediately relax to the homeostatic baseline stretch,
λe = λcrit. In the limit of τ → ∞, there would be
no growth and the elastic stretch would always remain
equal to the total stretch λe = λ. Figure 7 shows that
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Table 2 In vivo Holzapfel-Ogden parameters identified individually for each animal at baseline compared to ex vivo Holzapfel-
Ogden parameters in humans. Results are summarized as mean ± standard deviation; α and β are the animal-specific scaling
factors of the stiffnesses ai and exponential parameters bi from ex vivo human to in vivo pig.
ex vivo α β a¯ b¯ a¯f b¯f a¯s b¯s a¯fs b¯fs
[%] [%] [Pa] [-] [Pa] [-] [Pa] [-] [Pa] [-]
human 100.0 100.0 1050.0 7.54 3465.0 14.47 481.0 12.55 283.0 3.09
in vivo α β a b af bf as bs afs bfs
[%] [%] [Pa] [-] [Pa] [-] [Pa] [-] [Pa] [-]
pig #1 11.30 57.66 118.6 4.35 391.1 8.34 54.3 7.23 31.9 1.78
pig #2 15.62 68.64 164.0 5.18 540.6 9.93 75.1 8.61 44.1 2.12
pig #3 20.74 76.64 217.7 5.78 717.7 11.09 99.7 9.61 58.6 2.37
pig #4 10.01 57.36 105.1 4.32 346.5 8.30 48.1 7.20 28.3 1.77
pig #5 16.88 76.93 177.2 5.80 584.2 11.13 81.1 9.65 47.7 2.38
pig #6 13.07 58.37 137.2 4.40 452.2 8.45 62.8 7.32 36.9 1.80
mean 14.60 65.93 153.3 4.97 505.4 9.54 70.2 8.27 41.2 2.04
std ±3.95 ±9.40 ±41.5 ±0.71 ±136.9 ±1.36 ±19.0 ±1.18 ±11.2 ±0.29
for τ = 0.03 week and τ = 0.10 week, the response is
close to the first limit case, with a linear longitudinal
growth and a continuous relaxation of the elastic stretch
to the homeostatic baseline stretch, λe = λcrit. In other
words, for τ = 0.10 week, the growth model responds
fast enough to always accommodate the echocardio-
graphically measured increase in end diastolic volume.
For values larger than τ = 0.10 week, the growth model
responds slower than the measured increase in volume,
and elastic stretches λe > λcrit build up in the heart.
Given that τ = 0.10 week results in a fairly constant
growth rate ϑ˙‖, which is in correspondence with other
experimental volumetric overload studies [63], we se-
lected τ = 0.10 week for all future simulations. As
such, growth compensates the macroscopically observed
changes in cardiac dimensions within a proper time
frame, without building up a ‘growth lag’. As this study
set out to objectively assess the predictive power of an
established growth law, we did not tune the growth
speed parameter τ to the experimental data specifically.
Figure 8 highlights the regional, transmural, temporal,
and inter-animal variations of growth throughout our
study. The volume overload of 12.4%/week for pig # 3,
see Figure 3, triggered the largest longitudinal myocyte
growth of up to 88%; the volume overload of 2.5%/week
for pig # 1, see Figure 3, triggered the smallest growth
of up to 31%. Within each heart, growth displays no-
table transmural variations with larger values in the
endocardium, the inner wall, and smaller values in the
epicardium, the outer wall.
3.5 Growth model correctly predicts myocyte
lengthening
For each animal, we successfully propagated the un-
certainties of n = 500 end diastolic volumes from our
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Fig. 8 Regional, transmural, temporal, and inter-
animal variations of growth in response to left ven-
tricular overload. Longitudinal growth ϑ‖ displays notable
transmural variations with larger values in the endocardium,
the inner wall, and smaller values in the epicardium, the outer
wall. Growth is largest in pig #3 and smallest in pig #1.
echocardiography through the Gaussian process regres-
sion and obtained simulated myocyte morphologies,
which we compared against our experimentally mea-
sured myocyte morphologies from our histology. Fig-
ure 9 compares our computationally simulated myocyte
lengths across the entire left ventricular wall from the
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Fig. 9 Simulation and experiment of chronic myocyte
lengthening across the entire ventricular wall. Blue
and red probability density functions represent computation-
ally simulated and experimentally measured myocyte lengths
throughout the entire left ventricular wall, both with uncer-
tainty; percentage agreement refers to the region shared be-
tween both graphs. The average agreement between simula-
tion and experiment is 36.5%.
Gaussian process regression to our experimentally mea-
sured myocyte lengths. The blue and red probability
density functions represent simulation and experiment.
The probability density functions are a qualitative and
quantitative illustration of the intersubject variability
of cardiac growth. The overlap between the blue and
red graphs is a quantitative measure of the agreement
between the model prediction and the experiment [23].
The average agreement between simulation and experi-
ment is 36.5%, ranging from a good agreement of 67.4%
for pig #5 to a poor agreement of 1.0% for pig #2.
For all six animals, the blue graphs are located to the
left of the red graphs, which implies that the simula-
tion underestimates the degree of myocyte lengthen-
ing. Since our histological samples originate exclusively
from endocardial biopsies sampled at the inner wall, we
now perform the same analysis, but this time by only
using simulated myocyte lengths from the endocardial
wall to more closely represent our experimental setting.
Figure 10 compares our simulation of myocyte lengths
across the endocardial wall from the Gaussian process
regression to our experiment of histologically measured
myocyte lengths. The experimental data are the same
as in Figure 9, but now, the simulation only uses the
myocyte lengths in the endocardial wall (inner 10% of
the ventricular wall thickness). Similar to Figure 9, the
overlap between the blue and red graphs is a quan-
titative measure of the agreement between the model
prediction and the experiment. The average agreement
between simulation and experiment is 52.7%, ranging
from an excellent agreement of 85.7% for pig #5 to
a poor agreement of 6.0% for pig #2. For all six an-
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Fig. 10 Simulation and experiment of chronic my-
ocyte lengthening across the endocardial wall. Blue
and red probability density functions represent computation-
ally simulated and experimentally measured myocyte lengths
throughout the endocardial left ventricular wall, both with
uncertainty; percentage agreement refers to the region shared
between both graphs. The average agreement between simu-
lation and experiment is 52.7%.
imals, the blue graphs have now moved towards the
right and are closer to the red graphs than in Figure
9. This is in agreement with the regional variation of
growth in Figure 8, which suggests that myocyte length-
ening is larger in the endocardium, where the samples
were taken, than in the epicardium. If we exclude pig
#2, the largest pig of our study, from our analysis, the
agreement for the remaining five pigs is 62.0%. In other
words, for pigs #1, #3, #4, #5, and #6, the stretch-
driven growth law coupled to alterations in end dias-
tolic volume alone explain changes in myocyte length
by 62.0%. Taken together, Figure 10 suggests that el-
evated fiber stretches induced by an increase in dias-
tolic volume are the major stimulus of chronic myocyte
lengthening. Table 3 and Figure 11 compare the tem-
poral evolution of the computationally simulated and
experimentally measured changes in myocyte length.
The simulated mean myocyte length increases by 2.84%
per week, compared to the measured increase of 3.82%
per week. This results in a simulated volume increase of
22.7% throughout the period of eight weeks compared
to the experimentally measured increase of 30.6%. Pig
#5 displays the best agreement with a simulated and
measured weekly increase of 2.47% and 2.27% and an
almost perfect overlap in Figure 11; pig #2 displayed
the least agreement with 3.05% and 6.92% and virtually
no overlap in Figure 11.
4 Discussion
Cardiac growth is a complex process that affects the
heart across multiple time and length scales. Accurate
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Fig. 11 Simulation and experiment of chronic my-
ocyte lengthening across the endocardial wall. Blue
lines represent medians and shaded regions 95% confidence
intervals of computationally simulated myocyte lengthening
in the endocardial wall; red lines represent medians and
shaded regions 95% confidence intervals of experimentally
measured myocyte lengthening from endomyocardial biop-
sies, both with uncertainties.
Table 3 Simulation and experiment of chronic myocyte
lengthening across the endocardial wall. Computationally
simulated myocyte lengths are recorded across the endocar-
dial wall; experimentally measured myocyte lengths are de-
termined from endomyocardial biopsies.
pig ∆ml w0 w2 w4 w6 w8 ∆/week
#1 sim 1.00 1.02 1.04 1.07 1.09 +1.15%
exp 1.00 1.05 1.09 1.14 1.19 +2.43%
#2 sim 1.00 1.04 1.11 1.17 1.24 +3.05%
exp 1.00 1.12 1.25 1.39 1.55 +6.92%
#3 sim 1.00 1.09 1.20 1.31 1.42 +5.20%
exp 1.00 1.08 1.16 1.24 1.34 +4.20%
#4 sim 1.00 1.04 1.09 1.14 1.19 +2.40%
exp 1.00 1.07 1.14 1.21 1.29 +3.63%
#5 sim 1.00 1.04 1.09 1.14 1.20 +2.47%
exp 1.00 1.04 1.09 1.13 1.18 +2.27%
#6 sim 1.00 1.04 1.10 1.16 1.22 +2.78%
exp 1.00 1.06 1.13 1.20 1.28 +3.44%
overall sim 1.00 1.05 1.10 1.17 1.23 +2.84%
exp 1.00 1.07 1.14 1.22 1.31 +3.82%
prediction of this process in response to exercise, dis-
ease, devices, or drugs could form an important clinical
tool in designing new therapies for a range of patholog-
ical conditions. Recent reviews have begun to acknowl-
edge the importance of multiscale computational mod-
eling in providing additional insights into the patholog-
ical alterations of heart failure across the scales [6,16,
46,58]. Following the very first theoretical mathemati-
cal approach of biological growth in the mid 90s [48],
various groups have proposed different growth models
for the heart throughout the past decade [2,21,16,29,
25,45,65]. Motivated by numerous clinical [14,15,20,
40,56,58] and experimental [32,57,60,63] studies that
point to the importance of mechanical forces as modu-
lators of cardiac growth, most of these growth models
postulate mechanical measures as drivers for cardiac
growth. It is clear from the wide variety of proposed
growth laws that there still is considerable debate about
the specific driving forces for growth [65]. Naturally, to
identify the best basis for formulating growth models,
it is critical to quantify the predictive power of a model
in tight correlation with experimental data. However,
such an assessment is challenging for multiple reasons:
First, the highly patient-specific time course and ex-
tent of disease progression associated with hypertrophy
calls for subject-specific data collection and modeling;
second, the multiscale nature of cardiac growth requires
the characterization at multiple spatial scales ranging
from the subcellular via the cellular to the whole organ
level; third, the intrinsic uncertainty associated with
sparse experimental data has a strong influence on the
predicted outcome.
Here we proposed a novel approach to quantify the pre-
dictive power of cardiac growth modeling using tools
from machine learning. We designed a unique chronic
volume overload study and monitored growth longitu-
dinally, bi-weekly, across multiple spatial scales. We
created subject-specific computational ventricle mod-
els, exposed them to subject-specific loading conditions,
calibrated their subject-specific elastic material param-
eters under physiological conditions, and quantified the
predictive power of a multiscale stretch-driven growth
law under pathological conditions. Specifically, we per-
formed a systematic sensitivity analysis to explore the
role of the growth speed parameter, quantified uncer-
tainty in experimental measurements using hierarchi-
cal modeling and Bayesian inference, and propagated
the uncertainty through our subject-specific models us-
ing Gaussian process regression. In a previous purely
kinematic study [53], we have used our experimental
data to prescribe changes in cardiomyocyte dimensions
and characterize resulting alterations in cardiac size.
Now, we perform a dynamic study in which changes in
cardiomyocyte dimensions evolve naturally as a conse-
quence of the stretch-driven growth law. As such, this
study truly probes the predictive potential of a multi-
scale growth model that correlates macroscopic changes
in hemodynamic conditions to microscopic changes in
myocardial architecture and myocyte ultrastructure.
Importantly, nor the growth law, nor any growth pa-
rameter was tuned to lead to the best fit between sim-
ulated and experimental results. As such, we obtained
an objective assessment of the growth law’s predictive
power in correlation with the experimental data.
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4.1 Ex vivo testing overestimates the elastic stiffness
Our study characterizes the individual subject-specific
elastic response of myocardial tissue in the living heart
using the Holzapfel-Ogden model [18,22]. Most exist-
ing cardiac growth models are not based on study- and
subject-specific experimental data collected for such a
purpose. Instead, they adopt elastic model parameters
from previous studies designed for a different purpose
[33]. The mismatch from using experimental data of
other species or other studies, combined with the inter-
animal variability in elastic tissue behavior and left ven-
tricular geometry, highlights the importance of subject-
specific modeling to accurately compute the regional
stretch and stress distributions as potential drivers for
cardiac growth. Specifically, here we adopt a new two-
stage method [50], which establishes ratios of material
parameters using published ex vivo triaxial shear ex-
periments [59] and maps the ex vivo parameters onto
their subject-specific in vivo counterparts via two scal-
ing coefficients using our own pressure-volume data [53]
as showcased in Figure 6. The underlying assumption
to reduce the set of unknowns is that the ratios between
the four stiffness parameters a, af , as, and afs and the
four exponential model parameters b, bf , bs, and bfs re-
main unchanged in vivo and ex vivo, but their abso-
lute values change linearly via the scaling coefficients
α and β. Here, we identified the means of these coef-
ficients to α = 14.60% and β = 65.93%. Table 2 re-
veals that the subject-specific scaling coefficients α and
β display a relatively low standard deviation of 27.05%
and 14.26 % amongst the six animals, while their means
are significantly smaller than their ex vivo counterparts,
here 85.40% and 34.07%. This observation is significant
since it suggests that the ex vivo identified Holzapfel-
Ogden stiffness parameters [22] overestimate the my-
ocardial stiffness by more than one order of magnitude.
The drastic increase in myocardial stiffness from in vivo
to ex vivo is a collective result of ultrastructural and
architectural changes within the myocardial tissue post
mortem and upon explantation. This trend is consis-
tent with prior studies of α = 16.0% and β = 73.0%
for porcine [50] and α = 8.98% and β = 77.9% for
human [41] myocardial tissue in vivo. In summary, we
suggest using Holzapfel-Ogden stiffnesses of a = 153.3
Pa, af = 505.4 Pa, as = 70.2 Pa, and afs = 41.2 Pa,
and b = 4.97, bf = 9.54, bs = 8.27, and bfs = 2.04 when
simulating porcine myocardial tissue in vivo. Since the
standard deviations on these values were low–all less
than 30%–we can confidently recommend these values
for future simulations without the need to personalize
or re-identify these parameters again in future simula-
tions.
4.2 Growth displays temporal and regional variations
To illustrate the temporal evolution of growth, we per-
formed a systematic sensitivity analysis of the growth
parameter τ in Figure 7. Our myocyte morphologies in
Table 1 reveal that our mean myocyte lengthening of
+3.26%/week results in a total myocyte lengthening of
26.08% throughout the period of eight weeks, while the
mean myocyte width remains virtually constant with a
small reduction of -0.63%/week. This agrees well with a
human cardiomyopathy study in which myocyte lengths
from freshly isolated cardiac tissue were on average 40%
longer in the cardiomyopathy group than in the healthy
control group, while the myocyte widths displayed no
statistically significant differences between both groups
[14]. Our histology explains chronic myocyte lengthen-
ing through an increase in the mean serial sarcomere
number of +3.83%/week resulting in a total increase
in the serial sarcomere number of 30.64% within eight
weeks, while the mean sarcomere length remains un-
changed with a small increase of +0.02%/week. A previ-
ous chronic volume overload study in rabbits has shown
that myocytes compensate for chronic overstretch by
adding sarcomeres in series, initially at a constant rate
of approximately one sarcomere per day [63]. Our mean
myocyte lengths also increased linearly in time, from
85.45 to 107.75, by adding sarcomeres in series, from
47.50 to 62.07, at a constant rate of one sarcomere
per four days [53]. This agrees well with our sensitivity
analysis in Figure 7, from which we have rationalized
a growth parameter of τ = 0.10 weeks associated with
a linear increase in myocyte length ϑ‖ at a constant
rate ϑ˙‖. Our four-fold slower sarcomere addition in pigs
compared to rabbits [63] translates into a four-fold dif-
ference in the parameter τ , and could be a natural con-
sequence of the four-fold difference in metabolic rate
between pigs and rabbits [27].
To illustrate the regional, transmural, and intra-animal
variations of growth we plot the myocyte lengthening
ϑ‖ across the entire volume overloaded left ventricle
in Figure 8. Our model reveals a pronounced hetero-
geneity in the cellular response to volume overload with
myocytes in the endocardium, the inner wall, growing
more than myocytes in the epicardium, the outer wall.
These regional variations agree well with previous vol-
ume overload simulations in an idealized bi-ventricular
model [17] and in a personalized human heart model
[13], and with chronic volume overload experiments in
sheep [60], where myocyte lengthening was more pro-
nounced in the endocardial than in the epicardial wall.
The observed regional, transmural, and inter-animal
heterogeneity of growth elucidates the importance of
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subject-specific modeling of growth to avoid erroneous
results and conclusions.
4.3 Bayesian inference reveals chronic dilation and
myocyte lengthening
Our study characterizes volume overload induced
growth at a uniquely high spatial and temporal reso-
lution; however, it is still constrained by the natural
limitations of a chronic large animal study associated
with sparse and unevenly distributed data for each in-
dividual animal [53]. Using the concepts of hierarchical
modeling and Bayesian inference proved crucial to in-
terpret our experimental measurements in view of the
total cohort of animals. For example, pig #3 only has
n = 5 myocyte morphology recordings at week 4 and n
= 11 at week 8. Nonetheless, when interpreted within
the total cohort of all six subjects, we can observe clear
trends of pronounced myocyte lengthening at +4.3%
per week in Figure 4 and of marginal myocyte thinning
of -0.3% per week in Figure 5. Using tools from machine
learning to interpret our data also allows us to quantify
the uncertainty of our experimental measurements and
provides confidence in the finding that volume overload
triggers chronic dilation and myocyte lengthening. On
the whole organ level, our results in Table 1 and Fig-
ure 3 confirm the common understanding that a chronic
volume overload induces an increase in end diastolic
volume. This results in a decrease in ejection fraction,
from 55.6% to 47.7%, which agrees qualitatively with
clinical observations [31], but is quantitatively less pro-
nounced than in end-stage heart failure patients [14]. A
mean weekly increase in end diastolic volume of +5.95%
results in a total increase of 47.6% after only eight
weeks. These values are in good agreement with a clin-
ical study where 88 hypertensive patients were com-
pared to 29 healthy controls [47]. On the cellular level,
Figure 4 reveals significant changes in myocyte length
of +3.83% per week, whereas Figure 5 suggests negligi-
ble changes in the myocyte width of −0.63% per week.
The myocyte lengthening and fairly constant myocyte
width result in a myocyte length-to-width ratio of 6.3
at baseline and of 8.3 after eight weeks of volume over-
load. These results are in good agreement with the re-
ported myocyte length-to-width ratios ranging from 7.0
in the healthy left ventricle [4] to 11.5 in the failing left
ventricle [14]. Additionally, the approximately constant
width of the confidence intervals in Figures 3, 4 and 5
confirms that the linear evolution assumption on the
log-normal mean of the end diastolic volume, the my-
ocyte length, and the myocyte width in equation (7) is
appropriate to describe the temporal evolution of the
collected experimental data. In summary, using tools
from machine learning, hierarchical modeling, Bayesian
inference, and uncertainty quantification, proved criti-
cal to interpret our unevenly distributed data and to
quantify the intrinsic uncertainties in our experimental
measurements. Using these methods in real time – in
parallel to an ongoing study – could guide strategies of
adaptive sampling, for example by purposely selecting
non-equidistant, unevenly distributed time points to ef-
ficiently explore the parameter space and maximize the
information content of each measurement [54].
4.4 Uncertainty propagation provides quantitative
insight into the quality of our model
To date, there is no established method to bridge sub-
cellular, cellular, tissue, and organ levels and to charac-
terize how heart failure alters cardiac form and func-
tion across the scales. In a previous study, we have
used a purely kinematic approach to connect the sar-
comere, myocyte, myocardial, and whole heart levels
[53]. Here we use a dynamic approach and connect the
scales via a multiscale cardiac growth model to predict
how myocyte morphologies evolve dynamically as a re-
sult of ventricular volume overload. Most importantly,
we have designed an experimental study that collects
data across the scales to precisely quantify the predic-
tive features of our model. Specifically, our mechanistic
multiscale growth model is sensitive to volumetric over-
load, which initially drives individual myocytes away
from their homeostatic equilibrium state until they
have deposited enough sarcomeres in series to regain
homeostatic equilibrium. We quantify the uncertainties
in our volume overload recordings that drive myocyte
lengthening and propagated this uncertainty through
our growth model [43,44] to the predicted changes in
myocyte morphology. However, rather than performing
a computationally expensive growth simulation for each
realization, we create a computationally efficient surro-
gate model from Gaussian process regression and prop-
agate the uncertainties through this surrogate model
[42]. Figure 9 provides a side-by-side comparison of the
experimentally measured and the computationally pre-
dicted myocyte lengths after eight weeks, both with un-
certainties. The mean overlap between both graphs de-
fines the agreement of model and experiment of 36.5%.
Since the biweekly biopsy samples for our experimen-
tally measured myocyte morphologies were collected on
the endocardial surface of the left ventricle, we re-did
the analysis, but now by only sampling our computa-
tionally simulated myocyte morphologies across the en-
docardial wall. Figure 10 shows the quantitative com-
parison between experimentally measured and compu-
tationally predicted myocyte lengths. The agreement
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ranges from excellent with 85.7% for pig #5 to poor
with 6.0% for pig #2. On average, our growth model
displays a predictive power of 52.7% to predict myocyte
lengths from ventricular volume overload. The average
agreement of 36.5% and 52.7% in Figures 9 and 10 is
slightly lower than the average agreement of 54.0% in
our previous, purely kinematic analysis [53]. This ob-
servation is not unexpected, since our predictive growth
model of the dynamic evolution of myocyte lengths al-
lows for more freedom than our previous, purely kine-
matic enforcement of the correlation between the scales.
If we exclude pig #2, the largest pig and a potential
outliner, from this analysis, the predictive power in-
creases to 62.0%. Overall, this quantitative assessment
of our model suggests that other contributing factors,
e.g., myocardial disarray or extracellular matrix remod-
eling, could play an important role in heart failure and
should be included and quantified in future model re-
finements.
4.5 Limitations
This study proposes a new strategy to develop, cal-
ibrate, and validate a multiscale growth model that
tightly integrates experiment and simulation using tools
from machine learning. While this allows us, for the first
time, to quantify the predictive power of a stretch-based
growth law, our study has a few limitations: First, in
view of the relatively large inter-animal variability, our
initial number of six subjects seems rather low. With
our proposed methods, we can easily integrate new sub-
jects into our study and explore the predictive power of
our stretch-driven growth model for a larger group. This
could also help us to better explain the discrepancies for
pig #2 and to assess the uncertainty on the growth rate
parameter τ . Second, our subjects were all monitored
bi-weekly, throughout a limited time period of eight
weeks. In retrospect, it would have been interesting to
continue the study for a few more weeks to more closely
approach end stage heart failure. If we had known up-
front that we would use Bayesian inference to analyze
our data, we could have designed the study more inter-
actively and used adaptive sampling to more efficiently
sample the parameter space. Third, we have selected a
relatively simple growth model with only one free pa-
rameter, the parameter τ . While we have rationalized
this parameter from a systematic sensitivity analysis
and other experimental studies, a follow-up study could
try to ‘learn’ this parameter from the experimental data
specifically. However, a longer study interval would be
needed to truly identify the growth parameter τ and
compare our simple stretch-driven model to more com-
plex stretch- or stress-driven models for growth. For the
considered stretch-driven growth law, a mere tuning of
τ to the temporally changing histology data is not ex-
pected to improve the overlap. More specifically, the
τ = 0.10 week rationalization renders nearly-maximal
longitudinal growth for the considered growth law and
still underestimates the myocyte lengthening at week 8
for pig #1, #2 and #4. Fourth, we have induced left
ventricular volume overload in pigs through controlled
regurgitation to ultimately gain insight into the pro-
gression of heart failure in humans. While ventricular
volumes and myocyte dimensions are relatively compa-
rable between pigs and humans, it remains to be shown
to which extent the timeline of cellular and ventric-
ular adaptation to volume overloaded pigs translates
into the timeline of heart failure in humans. Finally,
when creating our subject-specific ventricle models at
baseline, multiple modeling aspects including the con-
stitutive material parameters, the ventricular geometry,
the myofiber architecture, and the boundary conditions,
can have a potential effect on the predicted ventricular
mechanics [5,10,41,49]. Quantifying the effect of each
of these modeling aspects is beyond the scope of this
study. Instead, we followed the current best practice to
create deterministic subject-specific ventricular models
for each pig at baseline [50].
5 Conclusion
Multiscale cardiac growth models hold huge promise for
simulating the patient-specific timeline of heart failure
and for optimizing surgical or pharmacological treat-
ment strategies. While scientists are increasingly recog-
nizing the predictive potential of cardiac growth mod-
els, the clinical community is rather skeptical, mainly
because the predictive power of these models remains
unknown. Here we design a new approach to quan-
tify the predictive power of cardiac growth models by
combining multiscale experiments and simulations us-
ing tools of machine learning. We adopt techniques of
hierarchical modeling, Bayesian inference, and Gaus-
sian process regression to quantify the uncertainty of
our experimental measurements and propagate this un-
certainty through a surrogate model for cardiac growth
to predict changes in myocyte morphology. Our results
suggest that stretch-driven growth is the major contrib-
utor to alterations in myocyte morphology. Our sim-
ple growth model alone can explain 52.7% of the ob-
served changes in myocyte length. Using machine learn-
ing in heart failure research allows us to seamlessly in-
tegrate experimental, computational, and clinical data
from different scales and times and to design efficient
experimental and clinical studies that adaptively sam-
ple the parameter space at varying points in space and
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time. Machine learning tools naturally provide high-
resolution quantitative insight into the quality of the
experiments and the predictive potential of the models.
Ultimately, our approach has the potential to combine
information from different sources, subjects, and scales
to provide a more holistic picture of the failing heart
and point towards new treatment strategies.
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